Of course, the rest is history. While they were waiting for the science to progress to utilize AP1903, their wonderful lab started producing cancer molecules, and this changed the direction of the company from a gene regulating company to an oncloogy company and they eventually licensed the technology to Bellicum, who I believe is headed by a Dr. who was originally with Ariad, or at least associated with them.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.